Correlation Between Viatris and Organon
Can any of the company-specific risk be diversified away by investing in both Viatris and Organon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viatris and Organon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viatris and Organon Co, you can compare the effects of market volatilities on Viatris and Organon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viatris with a short position of Organon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viatris and Organon.
Diversification Opportunities for Viatris and Organon
Excellent diversification
The 3 months correlation between Viatris and Organon is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Viatris and Organon Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organon and Viatris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viatris are associated (or correlated) with Organon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organon has no effect on the direction of Viatris i.e., Viatris and Organon go up and down completely randomly.
Pair Corralation between Viatris and Organon
Given the investment horizon of 90 days Viatris is expected to generate 0.71 times more return on investment than Organon. However, Viatris is 1.42 times less risky than Organon. It trades about 0.03 of its potential returns per unit of risk. Organon Co is currently generating about -0.03 per unit of risk. If you would invest 1,114 in Viatris on August 27, 2024 and sell it today you would earn a total of 223.00 from holding Viatris or generate 20.02% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viatris vs. Organon Co
Performance |
| Timeline |
| Viatris |
| Organon |
Viatris and Organon Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viatris and Organon
The main advantage of trading using opposite Viatris and Organon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viatris position performs unexpectedly, Organon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will offset losses from the drop in Organon's long position.| Viatris vs. Catalent | Viatris vs. Bausch Health Companies | Viatris vs. Tilray Inc | Viatris vs. Takeda Pharmaceutical Co |
| Organon vs. Johnson Johnson | Organon vs. Bristol Myers Squibb | Organon vs. AbbVie Inc | Organon vs. Eli Lilly and |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world |